We are live on ! Find out more
VCG

Vantage Consulting Group Portfolio holdings

AUM $19.7M
1-Year Est. Return 280.87%
This Fund
S&P 500
This Quarter Est. Return
+17.65%
1 Year Est. Return
+280.87%
3 Year Est. Return
+261.08%
5 Year Est. Return
+180.34%
10 Year Est. Return
–
AUM
$1.23B
AUM Growth
–
Cap. Flow
+$1.06B
Cap. Flow %
86.51%
Top 10 Hldgs %
94.5%
Holding
1,884
New
1,883
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
RPRX icon
Royalty Pharma
RPRX
+$911M
2
ADCT icon
ADC Therapeutics
ADCT
+$55.1M
3
KYNB
Kyntra Bio
KYNB
+$25.5M
4
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$5.96M
5
KR icon
Kroger
KR
+$366K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 95.04%
2 Technology 0.89%
3 Consumer Discretionary 0.79%
4 Industrials 0.61%
5 Consumer Staples 0.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACGL icon
1701
Arch Capital
ACGL
$34.3B
$1K ﹤0.01%
+34
New +$1.12K
AGIO icon
1702
Agios Pharmaceuticals
AGIO
$1.79B
$1K ﹤0.01%
+18
New +$712
AGNC icon
1703
AGNC Investment
AGNC
$12.4B
$1K ﹤0.01%
+74
New +$1.09K
ALLY icon
1704
Ally Financial
ALLY
$13.2B
$1K ﹤0.01%
+40
New +$1.21K
ALNY icon
1705
Alnylam Pharmaceuticals
ALNY
$27.5B
$1K ﹤0.01%
+7
New +$935
ALSN icon
1706
Allison Transmission
ALSN
$9.5B
$1K ﹤0.01%
+14
New +$563
AMH icon
1707
American Homes 4 Rent
AMH
$12B
$1K ﹤0.01%
+41
New +$1.2K
APLE icon
1708
Apple Hospitality REIT
APLE
$3.9B
$1K ﹤0.01%
+53
New +$629
APO icon
1709
Apollo Global Management
APO
$72.4B
$1K ﹤0.01%
+18
New +$804
ARES icon
1710
Ares Management
ARES
$28.9B
$1K ﹤0.01%
+18
New +$814
ARRY icon
1711
Array Technologies
ARRY
$803M
$1K ﹤0.01%
+32
New +$1.29K
AVTR icon
1712
Avantor
AVTR
$9.32B
$1K ﹤0.01%
+34
New +$876
AWI icon
1713
Armstrong World Industries
AWI
$7.38B
$1K ﹤0.01%
+10
New +$723
AXS icon
1714
AXIS Capital
AXS
$7.68B
$1K ﹤0.01%
+22
New +$1.07K
AZEK
1715
DELISTED
The AZEK Co
AZEK
$1K ﹤0.01%
+22
New +$794
BAH icon
1716
Booz Allen Hamilton
BAH
$8.39B
$1K ﹤0.01%
+8
New +$680
BHP icon
1717
BHP
BHP
$215B
$1K ﹤0.01%
+20
New +$1K
CMRC
1718
Commerce.com Inc Series 1
CMRC
$258M
$1K ﹤0.01%
+11
New +$878
BILL icon
1719
BILL Holdings
BILL
$4.49B
$1K ﹤0.01%
+5
New +$590
BLUE
1720
DELISTED
bluebird bio
BLUE
$1K ﹤0.01%
+1
New +$634
BMRN icon
1721
BioMarin Pharmaceuticals
BMRN
$11.6B
$1K ﹤0.01%
+11
New +$872
BPOP icon
1722
Popular Inc
BPOP
$11.2B
$1K ﹤0.01%
+23
New +$1.09K
BRKR icon
1723
Bruker
BRKR
$9.57B
$1K ﹤0.01%
+20
New +$959
CACC icon
1724
Credit Acceptance
CACC
$5.95B
$1K ﹤0.01%
+4
New +$1.31K
CCK icon
1725
Crown Holdings
CCK
$12.8B
$1K ﹤0.01%
+5
New +$460
67 68
69
70 71

Similar funds

MVG
Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return
NCM
Northwest Capital Management Lake Oswego, Oregon $23.1M AUM 13.6% 1-Year Est. Return
FFGIM
Founders Fund Growth II Management San Francisco, California $23.7M AUM
PIM
Profit Investment Management North Bethesda, Maryland $24.7M AUM 21.29% 1-Year Est. Return
HFG
Harborfront Financial Group Ludington, Michigan $13.4M AUM
SWM
Stark Wealth Management Bethlehem, Pennsylvania $26.6M AUM 23.19% 1-Year Est. Return
ICM
Infini Capital Management Central, Hong Kong $12.4M AUM 53.5% 1-Year Est. Return
SM
Southport Management Wilson, Wyoming $28.6M AUM 41.61% 1-Year Est. Return

Vantage Consulting Group's Q4 2020 Portfolio in Review

Q4 2020 is the first quarter with a 13F filing on record for Vantage Consulting Group, which disclosed 1,884 positions worth $1.23B. Its ten largest holdings account for 94% of the portfolio.

Its largest position is Royalty Pharma: 21,477,282 shares worth $1.07B.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, followed by Technology and Consumer Discretionary.

  • Vantage Consulting Group's largest Q4 2020 buy was Royalty Pharma: 21,477,282 shares worth $1.07B.
  • Vantage Consulting Group's ten largest holdings make up 94% of its $1.23B portfolio in Q4 2020.
  • Vantage Consulting Group disclosed 1,884 positions in Q4 2020, its first 13F filing on record.

Based on Vantage Consulting Group's 13F filing for Q4 2020, filed 12 Feb 2021.